Hospira Recalls Lactated Ringer's Injection Due to Sterility Concerns
Hospira is recalling 6,193,416 bags of Lactated Ringer's Injection because potential punctures may compromise sterility and cause leaks.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II, which corresponds to a 'Severe' rating under the rubric for potential serious health consequences.
Plain-English summary
Hospira Inc. is recalling 6,193,416 bags of Lactated Ringer's Injection, USP, 1000 mL containers. The product is prescription-only and was distributed nationwide, as well as in Puerto Rico and the U.S. Virgin Islands. The recall involves specific lots with expiration dates ranging from August 2015 to December 2015.
The recall was initiated due to a lack of assurance of sterility. The source text indicates a potential for punctures through the overwrap and primary container, which may result in IV bag leaks. This defect could compromise the sterile nature of the intravenous solution.
Healthcare providers and patients should stop using the affected lots immediately. Consumers should check their inventory for the specific lot numbers and expiration dates listed in the recall notice. If the product is found, it should be returned to the supplier or disposed of according to local regulations.
The recalled product
- Product
- Lactated Ringer's Injection, USP, 1000 mL container, Rx Only, Manufactured by Hospira, Inc., Lake Forest, IL 60045 NDC 0409-7953-09.
- Manufacturer
- Hospira Inc.
- Category
- Drug — Intravenous Solution
- Affected units
- 6,193,416
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (10)
- Lot # 32-099-JT
- Exp. 08/15 Lot # 32-103-JT
- Exp. 08/15 Lot # 34-070-JT
- Exp. 10/15 Lot # 34-086-JT
- Exp. 10/15 Lot # 34-165-JT
- Exp. 10/15 Lot # 35-085-JT
- Exp. 11/15 Lot # 35-115-JT
- Exp. 11/15 Lot # 35-121-JT
- Exp. 11/15 Lot # 36-057-JT
- Exp. 12/15
Distribution
Part of a larger recall action
This product is one of 11 recalled by Hospira Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 11 products in this recall →Related recalls
Same manufacturer · Hospira Inc.
See all →- CriticalHospira Recalls Dextrose Injection Syringes Due to Human Hair Particulate
FDA (Drugs) · 2017-05-31
- ModerateHospira Recalls Minibore Extension Sets Due to Solvent Occlusion
FDA (Devices) · 2017-01-18
- LowHospira Recalls Lidocaine and Dextrose Injection for Stability Failures
FDA (Drugs) · 2016-12-14
- SevereHospira Recalls Fentanyl Citrate Injection Ampules Due to Broken Tips
FDA (Drugs) · 2016-11-30
- HighHospira Symbiq Infusion Pump Recalled for White Screen Shutdown
FDA (Devices) · 2016-11-16
Same hazard · sterility compromise
See all →- ModerateAVID Medical Recalls Halyard IV Start Kits Due to Packaging Seal Issues
FDA (Devices) · 2026-09-30
- HighMedline Recalls Cataract Convenience Kits Due to Open Sterile Seals
FDA (Devices) · 2026-09-23
- HighMedline Myringotomy Kits Recalled for Potential Sterility Compromise
FDA (Devices) · 2026-09-23
- HighMedline Anesthesia Pain Kits Recalled for Potential Sterility Compromise
FDA (Devices) · 2026-09-23
- HighMaquet Percutaneous Insertion Kit Recalled for Sterile Barrier Integrity Issues
FDA (Devices) · 2026-09-23
Similar recalls
- LowHospira Recalls Lactated Ringer's Injection Due to CGMP Deviations
FDA (Drugs) · 2013-04-03
- CriticalHospira Recalls Lactated Ringer's Injection Due to Confirmed Mold Particulates
FDA (Drugs) · 2015-02-25
- CriticalHospira Recalls Lactated Ringer's Injection Due to Mold Contamination
FDA (Drugs) · 2013-04-24
- CriticalHospira Recalls Lactated Ringer's Irrigation Bags Due to Mold Contamination
FDA (Drugs) · 2015-06-03
- CriticalHospira Recalls Lactated Ringer's Injection Due to Non-Sterility
FDA (Drugs) · 2013-04-24
- SevereICU Medical Recalls Lactated Ringer's Injection Due to Particulate Matter
FDA (Drugs) · 2019-11-13